Avidity Biosciences, Inc.
NUCLEIC ACID COMPOSITIONS AND METHODS OF MULTI-EXON SKIPPING
Last updated:
Abstract:
Disclosed herein are oligonucleotide conjugates and pharmaceutical compositions for inducing multi-exon skipping. In some instances, also disclosed herein are methods of treating a muscular dystrophy, including treating Duchenne muscular dystrophy or Becker muscular dystrophy.
Status:
Application
Type:
Utility
Filling date:
24 Apr 2020
Issue date:
28 Jul 2022